Laboratory monitoring of biologic therapiesCUSH, J. J; YAZICI, Y.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 5, pp S90-S92, issn 0392-856X, SUP39Article

The autoimmunologist : geoepidemiology, a new center of gravity, and prime time for autoimmunitySHOENFELD, Yehuda; SELMI, Carlo; ZIMLICHMAN, Eyal et al.Journal of autoimmunity (Print). 2008, Vol 31, Num 4, pp 325-330, issn 0896-8411, 6 p.Article

Severity levels in psoriasis : A separate 'very severe' category not requiredKULKARNI, Amit S; HORN, Elizabeth; BALKRISHNAN, Rajesh et al.Journal of dermatological treatment. 2009, Vol 20, Num 1, pp 48-51, issn 0954-6634, 4 p.Article

Monitoring Antigen-Specific Biologics: Current Knowledge and Future ProspectsZANDVLIET, Maarten L; VAN BEZOOIJEN, Jine S; BOS, Mariska A et al.Therapeutic drug monitoring. 2013, Vol 35, Num 5, pp 588-594, issn 0163-4356, 7 p.Article

Teledermatological Monitoring of Psoriasis Patients on Biologic TherapyKOLLER, Silvia; HOFMANN-WELLENHOF, Rainer; HAYN, Dieter et al.Acta dermato-venereologica. 2011, Vol 91, Num 6, pp 680-685, issn 0001-5555, 6 p.Article

Efficacy of Systemic Treatments for Moderate to Severe Plaque Psoriasis: Systematic Review and Meta-AnalysisBANSBACK, Nick; SIZTO, Sonia; HUIYING SUN et al.Dermatology (Basel). 2009, Vol 219, Num 3, pp 209-218, issn 1018-8665, 10 p.Article

Marked Improvement in Nail Psoriasis during Treatment with AdalimumabIRLA, N; YAWALKAR, N.Dermatology (Basel). 2009, Vol 219, Num 4, pp 353-356, issn 1018-8665, 4 p.Article

The Sheffield rheumatoid arthritis health economic modelTOSH, Jonathan; BRENNAN, Alan; WAILOO, Allan et al.Rheumatology (Oxford. Print). 2011, Vol 50, issn 1462-0324, iv26-iv31, SUP4Conference Paper

Die immunmodulierende Therapie verbessert die Lebensqualität bei rheumatoider Arthritis : Lebensqualität bei rheumatischen Erkrankungen = Immunomodulatory therapy improves quality of life with rheumatoid arthritis : Quality of life in rheumatic diseasesGRANINGER, W.Zeitschrift für Rheumatologie (Print). 2010, Vol 69, Num 3, pp 210-212, issn 0340-1855, 3 p.Article

Rituximab use in everyday clinical practice as a first-line biologic therapy for the treatment of DMARD-resistant rheumatoid arthritisMCGONAGLE, D; TAN, A. L; MADDEN, J et al.Rheumatology (Oxford. Print). 2008, Vol 47, Num 6, pp 865-867, issn 1462-0324, 3 p.Article

Treatment of Tendinopathies with Platelet-rich PlasmaMAUTNER, Ken; KNEER, Lee.Physical medicine and rehabilitation clinics in North America. 2014, Vol 25, Num 4, issn 1047-9651, 865-880, ix [17 p.]Article

Reisen bei rheumatischen Erkrankungen: Auswahl des Reiseziels und Umgang mit Medikamenten : Reisemedizin = Travelling of patients with rheumatic diseases. Choice of destination and handling of medication : Travel medicineHERMANN, W.Zeitschrift für Rheumatologie (Print). 2011, Vol 70, Num 4, issn 0340-1855, 286-291 [5 p.]Article

Detection and evaluation of a drug safety signal concerning pancreatic cancer: lessons from a joint approach of three European biologics registersSTRANGFELD, Anja; HYRICH, Kimme; ZINK, Angela et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 1, pp 146-151, issn 1462-0324, 6 p.Article

The Knowns and Unknowns of Biologic Therapy in Ankylosing SpondylitisGENSLER, Lianne; INMAN, Robert; DEODHAR, Atul et al.The American journal of the medical sciences (Print). 2012, Vol 343, Num 5, pp 360-363, issn 0002-9629, 4 p.Conference Paper

Report on malignancies in the German juvenile idiopathic arthritis registryHORNEFF, Gerd; FOELDVARI, Ivan; MINDEN, Kirsten et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 1, pp 230-236, issn 1462-0324, 7 p.Article

Mechanisms of Adverse Drug Reactions to BiologicsCLARKE, Janet B.Handbook of experimental pharmacology. 2010, Vol 196, pp 453-474, issn 0171-2004, 22 p.Article

Etanercept at Different Dosages in the Treatment of Generalized Pustular Psoriasis : A Case SeriesESPOSITO, M; MAZZOTTA, A; CASCIELLO, C et al.Dermatology (Basel). 2008, Vol 216, Num 4, pp 355-360, issn 1018-8665, 6 p.Article

Infliximab then Efalizumab, the 'Hit and Run' Approach Does Not WorkBARDE, C; THIELEN, A. M; SAURAT, J.-H et al.Dermatology (Basel). 2008, Vol 216, Num 2, pp 171-172, issn 1018-8665, 2 p.Article

New-onset, debilitating arthritis in psoriasis patients receiving efalizumab : PsoriasisMYERS, Wendy A; NAJARIAN, David; GOTTLIEB, Alice B et al.Journal of dermatological treatment. 2006, Vol 17, Num 6, pp 353-354, issn 0954-6634, 2 p.Article

Biologics in development for rheumatoid arthritis : Relevance to osteoarthritisABRAMSON, Steven B; YAZICI, Yusuf.Advanced drug delivery reviews. 2006, Vol 58, Num 2, pp 212-225, issn 0169-409X, 14 p.Article

T cell targeted immunotherapy for autoimmune diseaseLEE, Erica; SINHA, Animesh A.Autoimmunity (Print). 2005, Vol 38, Num 8, pp 577-596, issn 0891-6934, 20 p.Article

Protein aggregation and lyophilization: Protein structural descriptors as predictors of aggregation propensityROUGHTON, Brock C; IYER, Lavanya K; BERTELSEN, Esben et al.Computers & chemical engineering. 2013, Vol 58, pp 369-377, issn 0098-1354, 9 p.Article

Genomics in mammalian cell culture bioprocessingWUEST, Diane M; HARCUM, Sarah W; LEE, Kelvin H et al.Biotechnology advances. 2012, Vol 30, Num 3, pp 629-638, issn 0734-9750, 10 p.Article

Outcomes of ileocolic resection and right hemicolectomies for Crohn's patients in comparison with non-Crohn's patients and the impact of perioperative immunosuppressive therapy with biologics and steroids on inpatient complicationsMASCARENHAS, Christopher; NUNOO, Robert; ASGEIRSSON, Theodor et al.The American journal of surgery. 2012, Vol 203, Num 3, pp 375-378, issn 0002-9610, 4 p.Article

Advances and challenges in analytical characterization of biotechnology products: Mass spectrometry-based approaches to study properties and behavior of protein therapeuticsKALTASHOV, Igor A; BOBST, Cedric E; ABZALIMOV, Rinat R et al.Biotechnology advances. 2012, Vol 30, Num 1, pp 210-222, issn 0734-9750, 13 p.Article